Century Therapeutics (IPSC) Receivables - Accured (2023 - 2025)
Century Therapeutics (IPSC) reported Receivables - Accured of $393000.0 for Q4 2025, down 68.66% year-over-year from $1.3 million in Q4 2024, and down 68.66% quarter-over-quarter from $1.3 million in Q4 2024.
Century Therapeutics (IPSC) Receivables - Accured (2023 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has 3 years of Receivables - Accured data on file, last reported at $393000.0 in Q4 2025.
- Receivables - Accured for Q4 2025 came in at $393000.0, down 68.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $393000.0 (down 68.66% YoY), and the FY2025 annual result was $393000.0, down 68.66% from the prior year.
- Receivables - Accured fell to $393000.0 in Q4 2025 per IPSC's latest filing, from $1.3 million in the prior quarter.
- Over five years, Receivables - Accured peaked at $1.6 million in Q4 2023 and troughed at $393000.0 in Q4 2025.
- A 3-year average of $1.1 million and a median of $1.2 million in 2023 frame the typical range for Receivables - Accured.
- The sharpest annual moves came in 2024 and 2025: Receivables - Accured slipped 20.13% in 2024, then tumbled 68.66% in 2025.
- A 3-year view of Receivables - Accured shows it stood at $1.6 million in 2023, then decreased by 20.13% to $1.3 million in 2024, then plunged by 68.66% to $393000.0 in 2025.
- Business Quant data shows IPSC's Receivables - Accured at $393000.0 in Q4 2025, $1.3 million in Q4 2024, and $1.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acc. Int. Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 393,000.00 |
| Dec 31, 2025 | 393,000.00 |
| Dec 31, 2024 | 1.25 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 855,000.00 |
| Mar 31, 2023 | 855,000.00 |